We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Yissum Signs a Collaboration Agreement with Aurum Ventures MKI

News   Jun 29, 2009

 
Yissum Signs a Collaboration Agreement with Aurum Ventures MKI
 
 
 

RELATED ARTICLES

Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy

News

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have now identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.

READ MORE

Compound Created to Block Therapeutic Target in Blood Cancer

News

Researchers have discovered a hyperactive cell signal that contributes to tumor growth in an aggressive blood cancer. The team has also developed an experimental therapeutic "UNC3810A" to block the signal and slow tumor growth.

READ MORE

The Device That Makes Your Blood Run Cold

News

A wrist strap which cools a person’s blood flow has been developed to sooth people during heatwaves. The Climati could help athletes in difficult conditions and support older people in rising temperatures.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE